MedTrace Logo

Registry Study on Respiratory Monogenic Diseases in Chinese Children

NCT03528525 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-05-18

No results posted yet for this study

Summary

This study is a multicenter, prospective cohort study of patients diagnosed with respiratory monogenic diseases, the clinical information of recruited patients, including clinical manifestations, lung function, chest imaging, quality of life and other indicators, will be followed for 5 years.

Conditions

  • Monogenic Diseases

Interventions

OTHER

observation

Sponsors & Collaborators

  • Capital Institute of Pediatrics, China

    collaborator OTHER

  • Shengjing Hospital

    collaborator OTHER

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • The Children's Hospital of Zhejiang University School of Medicine

    collaborator OTHER

  • Children's Hospital of Chongqing Medical University

    collaborator OTHER

  • The first clinical college of Guangzhou medical university

    collaborator UNKNOWN

  • Guangzhou Women and Children's Medical Center

    collaborator OTHER

  • Yuying Children's Hospital of Wenzhou Medical University

    collaborator OTHER

  • Kunling Shen

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-01-01
Completion
2030-12-30
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03528525 on ClinicalTrials.gov